Innovent Biologics, Inc. (HKG:1801)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
50.25
+0.40 (0.80%)
Apr 3, 2025, 4:08 PM HKT

Innovent Biologics Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Net Income
--1,028-2,179-2,729-998.42
Upgrade
Depreciation & Amortization
-310.22276.79202.1785.63
Upgrade
Other Amortization
-74.8942.642.58-
Upgrade
Loss (Gain) From Sale of Assets
-0.95-0.060.711.2
Upgrade
Asset Writedown & Restructuring Costs
-115.36---
Upgrade
Loss (Gain) From Sale of Investments
--30.81-5.1-125.02-30.98
Upgrade
Stock-Based Compensation
-574.2469.49501.57402.5
Upgrade
Other Operating Activities
--272.47-833.19213.88566.44
Upgrade
Change in Accounts Receivable
--430.62393.14-493.03-225.34
Upgrade
Change in Inventory
-358.95-105.39-643.28-311.43
Upgrade
Change in Accounts Payable
-46.93130.5774.4336.35
Upgrade
Change in Unearned Revenue
--138.63205.04105.4355.12
Upgrade
Change in Other Net Operating Assets
-566.77-313.45864.46111.24
Upgrade
Operating Cash Flow
-147.81-1,919-2,025-307.69
Upgrade
Capital Expenditures
--1,119-896.9-1,066-489.02
Upgrade
Sale of Property, Plant & Equipment
-0.050.190.10.04
Upgrade
Sale (Purchase) of Intangibles
--262.35-468.6-781.88-32.63
Upgrade
Investment in Securities
--204.43-384.74-254.58-4,490
Upgrade
Other Investing Activities
-571.22314.87-596.15-173.02
Upgrade
Investing Cash Flow
--998.66-1,435-2,698-5,185
Upgrade
Long-Term Debt Issued
-1,3361,0801,463372.18
Upgrade
Long-Term Debt Repaid
--948.85-392.74-278.72-33.79
Upgrade
Net Debt Issued (Repaid)
-386.7687.431,184338.39
Upgrade
Issuance of Common Stock
-2,2552,1313,9514,662
Upgrade
Other Financing Activities
--54.5673.59-131.52-88.63
Upgrade
Financing Cash Flow
-2,5872,8925,0034,912
Upgrade
Foreign Exchange Rate Adjustments
--6.88118.66-197.14-569.47
Upgrade
Net Cash Flow
-1,730-343.2483.23-1,150
Upgrade
Free Cash Flow
--971.58-2,816-3,090-796.71
Upgrade
Free Cash Flow Margin
--15.65%-61.80%-72.38%-20.73%
Upgrade
Free Cash Flow Per Share
--0.62-1.89-2.12-0.59
Upgrade
Cash Interest Paid
-127.61104.8878.8345.83
Upgrade
Cash Income Tax Paid
--114.4266.126.44139.71
Upgrade
Levered Free Cash Flow
--907.54-2,475-2,612-806.08
Upgrade
Unlevered Free Cash Flow
--845.9-2,411-2,573-763.36
Upgrade
Change in Net Working Capital
-767.71-554-116.9-258.09381.6
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.